奥士康(002913) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥891,874,287.76, representing an increase of 18.58% compared to the same period last year[5] - Net profit attributable to shareholders was ¥108,745,847.14, up 37.34% year-on-year[5] - Basic earnings per share were ¥0.72, an increase of 30.56% year-on-year[5] - Total operating revenue for Q1 2022 reached CNY 1,057,591,838.50, an increase of 18.6% compared to CNY 891,874,287.76 in the same period last year[28] - Net profit for Q1 2022 was CNY 149,353,547.88, up 37.4% from CNY 108,745,847.14 in Q1 2021[32] - Basic and diluted earnings per share for Q1 2022 were both CNY 0.94, compared to CNY 0.72 in the previous year, reflecting a 30.6% increase[34] Cash Flow - The net cash flow from operating activities reached ¥39,031,163.83, reflecting a growth of 39.45% compared to the previous year[5] - Operating cash flow for the current period is ¥54,427,469.29, an increase of 39.5% compared to ¥39,031,163.83 in the previous period[36] - Total cash inflow from operating activities is ¥1,066,009,349.51, up from ¥745,187,142.12, reflecting a growth of 42.9%[36] - Cash inflow from financing activities decreased to ¥130,449,655.57 from ¥574,448,661.77, a decline of 77.3%[40] - Net cash flow from financing activities is ¥20,502,679.81, down 95.4% from ¥449,224,781.94 in the previous period[40] - The company reported a cash inflow of ¥43,189,210.70 from other operating activities, significantly higher than ¥13,606,391.36 previously, an increase of 217.5%[36] Assets and Liabilities - Total assets at the end of the reporting period were ¥7,413,963,101.00, a slight decrease of 0.27% from the end of the previous year[5] - The total assets of the company as of March 31, 2022, amounted to CNY 7,394,110,583.93, a slight decrease from CNY 7,413,963,101.00 at the beginning of the year[20] - The company’s total liabilities as of March 31, 2022, were not specified but included significant accounts payable of CNY 1,527,990,343.99[23] - Total liabilities decreased to CNY 3,721,484,300.12 from CNY 3,890,690,365.07, a reduction of approximately 4.3%[26] Research and Development - The company's R&D expenses increased by 34.70% to ¥52,850,037.39, indicating a focus on innovation[9] - Research and development expenses increased to CNY 52,850,037.39, up 34.9% from CNY 39,235,959.90 in the previous year[29] Investments - The company received government subsidies amounting to ¥41,720,734.65, a significant increase of 890.73% compared to the previous year[12] - The company reported a decrease of 52.33% in trading financial assets, primarily due to reduced investments in financial products[9] - The net cash flow from investing activities was negative at ¥110,920,488.61, a decline of 138.01% year-on-year, mainly due to increased principal recovery from financial products[12] - Cash inflow from investment activities totaled ¥856,711,378.21, compared to ¥687,884,818.05, marking an increase of 24.5%[40] Shareholder Actions - The company completed the repurchase and cancellation of 93,930 restricted stocks, reducing the total shares from 161,054,898 to 160,960,968[17] - The first employee stock ownership plan was terminated early, with 1,086,200 shares sold, representing 0.6841% of the total share capital[19] Future Plans - The company plans to procure no less than CNY 1 billion from Nanya Technology Co., Ltd. in 2022, with an expected annual growth of at least 30% during the cooperation period[19] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[28]